| Janine Collinge, MD | |
|
98 Clifton Ave, West Hartford, CT 06107-1720 | |
| (860) 453-0945 | |
| Not Available |
| Full Name | Janine Collinge |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology - Pediatric Ophthalmology And Strabismus Specialist |
| Location | 98 Clifton Ave, West Hartford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114193497 | NPI | - | NPPES |
| 200495460A | Medicaid | OK |
| Entity Name | Connecticut Children's Specialty Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669448882 PECOS PAC ID: 6002720117 Enrollment ID: O20031113000468 |
News Archive
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command.
Survivors of Ebola virus disease in Liberia had a higher prevalence of certain health issues-including uveitis (eye redness and pain), abdominal, chest, neurologic, and musculoskeletal abnormalities upon physical exam-when compared to a control group of household and community members who did not have a history of EVD, according to findings from an ongoing study published in the New England Journal of Medicine.
Pevion Biotech AG today announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied to humans to date. Defensomes offer opportunities for a wide range of prophylactic and therapeutic indications, where boosting of the body's own natural defense is beneficial.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
The U.N. Committee on the Elimination of Discrimination Against Women this week is expected to finalize and release a draft report that says the Czech Republic government has not completely answered allegations that more than 80 Roma, or Gypsy, women from 1986 through 2004 were sterilized in the country without informed consent.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Janine Collinge, MD 98 Clifton Ave, West Hartford, CT 06107-1720 Ph: (860) 453-0945 | Janine Collinge, MD 98 Clifton Ave, West Hartford, CT 06107-1720 Ph: (860) 453-0945 |
News Archive
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.S. Army Medical Research and Development Command.
Survivors of Ebola virus disease in Liberia had a higher prevalence of certain health issues-including uveitis (eye redness and pain), abdominal, chest, neurologic, and musculoskeletal abnormalities upon physical exam-when compared to a control group of household and community members who did not have a history of EVD, according to findings from an ongoing study published in the New England Journal of Medicine.
Pevion Biotech AG today announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied to humans to date. Defensomes offer opportunities for a wide range of prophylactic and therapeutic indications, where boosting of the body's own natural defense is beneficial.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
The U.N. Committee on the Elimination of Discrimination Against Women this week is expected to finalize and release a draft report that says the Czech Republic government has not completely answered allegations that more than 80 Roma, or Gypsy, women from 1986 through 2004 were sterilized in the country without informed consent.
› Verified 7 days ago
Donald James Salzberg, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 836 Farmington Ave, Suite 121, West Hartford, CT 06119 Phone: 860-233-2346 Fax: 860-236-3607 | |
Lyndon B. Lee, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1013 Farmington Ave, West Hartford, CT 06107 Phone: 860-233-2020 Fax: 860-236-4979 | |
Dr. Alan E Solinsky, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1013 Farmington Ave, West Hartford, CT 06107 Phone: 860-233-2020 Fax: 860-236-9008 | |
Dr. Isaiah Joseph Davies, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1043 Farmington Ave, West Hartford, CT 06107 Phone: 860-549-2020 Fax: 860-549-2025 | |
Dr. Alexander Rudolf Gaudio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1043 Farmington Ave, West Hartford, CT 06107 Phone: 860-549-2020 Fax: 860-549-2025 | |
Duane F Austin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 639 Park Rd, Suite #100, West Hartford, CT 06107 Phone: 860-521-9230 Fax: 860-521-1709 |